NeuroOne Medical Technologies Corporation
NMTC
$0.823
$0.0658.58%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.39M | 3.27M | 272.30K | 825.80K | 1.38M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.39M | 3.27M | 272.30K | 825.80K | 1.38M |
| Cost of Revenue | 670.10K | 2.52M | 1.24M | 1.74M | 1.06M |
| Gross Profit | 716.50K | 754.70K | -972.60K | -912.80K | 314.10K |
| SG&A Expenses | 1.94M | 2.04M | 1.84M | 1.88M | 2.00M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -3.00M | -- | -- | -- |
| Total Operating Expenses | 4.07M | 1.56M | 3.09M | 3.62M | 4.26M |
| Operating Income | -2.68M | 1.71M | -2.82M | -2.79M | -2.89M |
| Income Before Tax | -2.27M | 1.79M | -3.35M | -2.77M | -2.86M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.27M | 1.79M | -3.35M | -2.77M | -2.86M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.27M | 1.79M | -3.35M | -2.77M | -2.86M |
| EBIT | -2.68M | 1.71M | -2.82M | -2.79M | -2.89M |
| EBITDA | -2.61M | 1.78M | -2.75M | -2.73M | -2.83M |
| EPS Basic | -0.07 | 0.06 | -0.11 | -0.10 | -0.11 |
| Normalized Basic EPS | -0.05 | 0.04 | -0.07 | -0.06 | -0.07 |
| EPS Diluted | -0.07 | 0.06 | -0.11 | -0.10 | -0.11 |
| Normalized Diluted EPS | -0.05 | 0.04 | -0.07 | -0.06 | -0.07 |
| Average Basic Shares Outstanding | 31.11M | 30.84M | 29.81M | 27.35M | 25.91M |
| Average Diluted Shares Outstanding | 31.11M | 30.88M | 29.81M | 27.35M | 25.91M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |